Skip to main
EXEL
EXEL logo

Exelixis (EXEL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Exelixis (EXEL) Stock

About Exelixis (EXEL)

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Market cap$12.02B
Yesterday's volume1
Revenue (TTM)$2.3B
Avg. daily volume3.23M
EBITDA (TTM)$844.28M
Open$43.87
Price / earnings ratio20.00x
Yesterday's range$43.47 - $44.48
Debt / equity8.78x
52 week range$21.82 - $49.62
5 year debt / equity5.89x
Beta (LTM)0.49x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio3.5x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Exelixis Stock Rating

What analysts recommend for EXEL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 39%
Buy 25%
Hold 36%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for Exelixis stock is $12.02B

The current P/E ratio for Exelixis stock is 20

The 52-week high for Exelixis stock is $49.62. The current Exelixis stock price $undefined is 100.00% below its 52-week high

The 52-week low for Exelixis stock is $21.82. The current Exelixis stock price $undefined has increased 100.00% from its 52-week low

No, the Exelixis stock does not pay dividends to its shareholders

The target price for Exelixis stock is $35.52 based on the average of what a group of analyst think Exelixis stock could be worth at a future date. This is not a prediction by Public.com

How to buy Exelixis stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Exelixis stock

    Navigate to the Explore page. Then, type Exelixis into the search bar. When you see Exelixis stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Exelixis stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Exelixis Stock Earnings

The value each EXEL share was expected to gain vs. the value that each EXEL share actually gained.

Exelixis (EXEL) reported Q1 2025 earnings per share (EPS) of $0.62, beating estimates of $0.44 by 40.91%. In the same quarter last year, Exelixis's earnings per share (EPS) was $0.17. Exelixis is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.63.

Buy Exelixis (EXEL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.